ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,063Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 6645

$3.64M Total Retail Price of All Prescriptions

Rank: 18 out of 6645

379 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 379 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 27,469 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

69% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$125 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

77 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
EFFIENT 1,063 1,042 10 1 261
ATELVIA 1,060 1,007 10 2 91
LOVAZA 868 845 3 68
AMLODIPINE BESYLATE 705 675 4 2
BENICAR 691 662 10 5 84
LIVALO 674 647 10 6 274
NAMENDA 659 646 7 41
BYSTOLIC 607 602 8 110
TRILIPIX 560 542 10 9 178
PATADAY 511 480 10 183
TAMIFLU 510 473 10 11 334
CELEBREX 508 481 12 54
AZOR 441 437 10 13 152
LIDODERM 425 388 14 53
AZITHROMYCIN 405 375 15 44
DEXILANT 378 353 16 102
FLECTOR 368 356 10 17 230
RANEXA 337 327 18 276
NATEGLINIDE 305 301 10 19 220
CLOPIDOGREL 304 293 20 36
PLAVIX 275 266 21 49
SINGULAIR 265 249 22 76
CLONIDINE 264 244 10 23 308
SPIRIVA 264 244 23 65
CLOBETASOL PROPIONATE 262 247 25 228
TAMSULOSIN HCL 257 257 26 22
PREDNISONE 247 236 27 57
METOPROLOL SUCCINATE 241 223 28 24
FLUOCINONIDE 235 227 29 130
MONTELUKAST SODIUM 228 212 30 128
ATORVASTATIN CALCIUM 227 208 31 10
SIMVASTATIN 226 208 32 1
ENABLEX 226 219 32 301
LEVOFLOXACIN 226 207 32 83
ISOSORBIDE MONONITRATE ER 220 218 35 66
AVODART 219 219 36 99
DIOVAN 215 214 37 19
VOLTAREN 208 190 38 108
TRIAMCINOLONE ACETONIDE 204 188 39 55
JALYN 197 197 40 354
FUROSEMIDE 189 186 41 11
LOSARTAN POTASSIUM 184 159 42 12
COLCRYS 176 166 43 192
AMMONIUM LACTATE 174 171 44 266
LYRICA 171 166 45 127
WELCHOL 171 168 45 199
AMOXICILLIN 168 161 47 107
LEVOCETIRIZINE DIHYDROCHLORIDE 164 150 48 241
ZOLPIDEM TARTRATE 162 145 49 17
CRESTOR 162 153 49 34
RAPAFLO 159 157 51 246
ULORIC 156 154 52 227
GLIMEPIRIDE 155 150 53 47
RANITIDINE HCL 150 142 54 51
SUPRAX 150 146 10 54 406
METFORMIN HCL 148 141 56 7
JANUVIA 145 143 57 38
ACIPHEX 142 130 58 167
CARVEDILOL 141 139 59 25
MOXEZA 136 127 10 60 595
KOMBIGLYZE XR 133 133 61 297
OMEPRAZOLE 133 111 61 6
ACTOS 132 132 63 71
NEXIUM 130 126 64 40
EDARBI 126 126 10 65 430
ALFUZOSIN HCL 124 116 66 563
TRIBENZOR 124 124 66 257
CREON 124 118 66 114
METOCLOPRAMIDE HCL 121 106 69 120
BONIVA 120 118 70 191
LEVOTHYROXINE SODIUM 120 115 70 4
ANTARA 119 113 10 72 361
ACTOPLUS MET 118 118 73 275
CHLORHEXIDINE GLUCONATE 115 90 74 344
QUETIAPINE FUMARATE 109 105 75 101
LUNESTA 107 83 76 287
DULERA 103 96 77 300
DIPHENOXYLATE-ATROPINE 102 84 78 214
ACTOPLUS MET XR 99 99 10 79 637
CILOSTAZOL 98 88 80 202
MELOXICAM 98 80 80 46
NASONEX 97 89 82 126
WARFARIN SODIUM 93 93 83 16
URSODIOL 92 85 84 349
VALACYCLOVIR 92 83 84 271
EXELON 92 91 84 149
DALIRESP 91 84 87 408
AMITIZA 90 77 88 245
DONEPEZIL HCL 88 88 89 27
PROAIR HFA 84 72 90 32
RESTASIS 84 79 90 311
CLONIDINE HCL 84 77 90 56
JANUMET 83 83 93 132
GRALISE 82 68 10 94 656
CARBIDOPA-LEVODOPA 82 82 94 116
FINASTERIDE 80 80 96 73
ATENOLOL 80 77 96 8
NIASPAN 79 79 98 164
KETOCONAZOLE 79 68 98 196
PANTOPRAZOLE SODIUM 75 75 100 29
NITROSTAT 73 72 101 193
PIOGLITAZONE HCL 73 73 R 101 184
GABAPENTIN 72 58 103 18
ONGLYZA 69 64 104 168
LACTULOSE 68 59 105 125
ADACEL 66 61 106 212
GEMFIBROZIL 65 61 107 96
VESICARE 65 56 107 148
VICTOZA 3-PAK 65 53 107 365
HYDROCODONE-ACETAMINOPHEN 65 35 S3 107 5
METRONIDAZOLE 64 58 111 329
ACETAMINOPHEN-CODEINE 64 54 S3 111 80
MEGACE ES 64 62 R 111 382
TRAMADOL HCL 63 58 114 30
ULTICARE 63 60 114 433
SODIUM CHLORIDE 63 61 114 216
LEVEMIR FLEXPEN 63 63 114 237
SPRIX 62 58 10 118 693
SEROQUEL 62 56 118 208
VIREAD 60 59 120 259
METFORMIN HCL ER 60 52 120 89
TRANSDERM-SCOP 60 59 120 696
SURE COMFORT ALCOHOL 59 56 123 250
PATANOL 59 47 123 131
ZOVIRAX 58 50 125 528
TRADJENTA 58 58 125 401
DIOVAN HCT 58 53 125 64
CICLOPIROX 56 48 128 402
HYDROXYZINE HCL 54 52 R 129 161
ALENDRONATE SODIUM 54 52 129 14
DIGOXIN 52 49 131 59
LOSARTAN-HYDROCHLOROTHIAZIDE 52 49 131 62
ADVAIR DISKUS 51 50 133 45
ZETIA 51 47 133 87
PROCRIT 50 50 135 352
PROCTOZONE-HC 50 45 135 243
SPIRONOLACTONE 50 48 135 85
AMIODARONE HCL 50 49 135 160
SYMBICORT 50 42 135 153
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.